About Us

Founded in 2009 with the broad goal of contributing to the improvement of health in populations worldwide, the International Prevention Research Institute (iPRI) aims to increase prospects for prevention through training, education, prevention research and research into causes worldwide with a focus on low-income and lower-middle income countries. [About us...]

Approach

In a world of challenges, iPRI has developed the optimum methodology in biomedical research combining a thorough, high-level, academic approach with a practical focus on providing evidence-based information about clinical, epidemiological and prevention strategies. [Discover our approach...]

People

iPRI is composed of international faculty, senior research fellows, staff and oversight committees with years of experience in prestigious institutions. Their mutual passion is to deliver exclusively evidence-based conclusions and, when requested or required, subsequent recommendations. [Discover iPRI's people...]

Articles

Peer-reviewed articles are a clear indication of an institute’s regard for science. iPRI faculty are proud to be highly published (four faculty have an H-Index over 50) and cited (our Senior Faculty have over 85,000 citations) [More...].

Events

The International Prevention Research Institute is engaged and engages. We do so to further dialogue on matters that ultimately impact health and prevention. iPRI events include the National Cancer Institute Directors’ annual meeting held in Lyon during the Spring.

Peter Boyle

Peter Boyle, President of iPRI, was born in Glasgow, Scotland, and graduated BSc, PhD and DSc (Med) from the University of Glasgow, Faculty of Medicine. He is a Fellow of the Royal Society of Edinburgh, Fellow of the Royal College of Physicians and Surgeons of Glasgow, Fellow of the Royal College of Physicians of Edinburgh, Fellow of the Faculty of Public Health and Fellow of the Academy of Medical Science. He was elected Honorary Member of the Academy of Science of Hungary and [More...]

Welcome

The International Prevention Research Institute (iPRI) is an independent research institute with a staff of demonstrated world-class excellence and leadership. iPRI has unparalleled experience in epidemiological research and macro health planning with a record of delivering real health and economic value to a range of public and private sources including governments, universities, research institutes, non-governmental organisations and large multi-national concerns.

Our combined years of experience operating at the highest level have enabled iPRI to have a unique global network of support including Senior Academic figures and Governments Departments and their senior officials. This enables iPRI to have immediate access to a worldwide network of expertise.

Of interest...

Most visited sections of the iPRI website
Approach

Approach

iPRI represents a new concept in biomedical research combining a thorough, high-level, academic approach coupled with a practical focus on providing information about clinical, epidemiological and prevention strategies.

People

People

iPRI believes that studies are founded on exceptional competence and devotion to results. To this end, iPRI is continually growing its base of uniquely competent and recognized professionals.
News

News

iPRI is busy and getting busier as our work takes us farther afield. Find out what iPRI is doing across all continents.
Articles

Articles

Peer-reviewed articles are a clear indication of an institute's regard for science. iPRI faculty are proud to have increasingly high H-indices.
Books

Books

In coming years, iPRI will continue to publish its own works. To date, books such as the Epidemiology and Statistics textbook and World Breast Cancer Report demonstrate this commitment.
Contact

Contact

Quick contact: +33472171199.
To send us a message, visit our contact page.
Featured Videos

Professor Peter Boyle, Ph.D., President of the International Prevention Research Institute gave the keynote address during Susan G. Komen International Global Women’s Cancer Summit on  February 4, 2013 in Washington D.C. In addition to his broader analysis, Professor Boyle reiterated his emphasis on disparities in women’s cancer between high and low resource countries.

Professor Boyle was also pleased to present the iPRI / Komen for the Cure produced World Breast Cancer Report 2012 which was extremely well received.

ESMO 2012

Vienna, Austria: Friday 28 September – Tuesday 2 October

A record-breaking 16,394 delegates attended ESMO 2012 in Vienna: over the five days, 140 scientific and educational sessions were staged.

New studies that reveal for the first time the real economic and human costs of caring for cancer patients in Europe have been presented during the ESMO 2012 Congress of the European Society for Medical Oncology, in Vienna.

Images: Georges Mollon, other photographers, royalty-free stock photography or other copyright holders if mentioned.